Current Edition

How a Defined Informatics Entity is the Key to Bridging Pharma’s Data Divide

When the health authorities began placing further emphasis on medicinal product data standards, the overlap between regulatory operations and systems beyond the regulatory scope became increasingly apparent. Timm Pauli at PharmaLex explores this rapidly changing regulatory environment and the role of a defined cross-functional informatics entity – within R&D or beyond – in bridging the divide between the various functions and the technology and data that supports these functions.